Successful pharmaceutical-grade streptozotocin (STZ)-induced hyperglycemia in a conscious tethered baboon (Papio hamadryas) model

Patrice A. Frost, Shuyuan Chen, Marguerite J. Mezzles, Venkata Saroja Voruganti, Edna J. Nava-Gonzalez, Hector E. Arriaga-Cazares, Katy A. Freed, Anthony G. Comuzzie, Ralph A. Defronzo, Jack W. Kent, Paul A. Grayburn, Raul A. Bastarrachea

Producción científica: Articlerevisión exhaustiva

9 Citas (Scopus)


Background: Non-human primate (NHP) diabetic models using chemical ablation of β-cells with STZ have been achieved by several research groups. Chemotherapeutic STZ could lead to serious adverse events including nephrotoxicity, hepatotoxicity, and mortality. Methods: We implemented a comprehensive therapeutic strategy that included the tether system, permanent indwelling catheter implants, an aggressive hydration protocol, management for pain with IV nubain and anxiety with IV midazolam, moment-by-moment monitoring of glucose levels post-STZ administration, and continuous intravenous insulin therapy. Results: A triphasic response in blood glucose after STZ administration was fully characterized. A dangerous hypoglycemic phase was also detected in all baboons. Other significant findings were hyperglycemia associated with low levels of plasma leptin, insulin and C-peptide concentrations, hyperglucagonemia, and elevated non-esterified fatty acids (NEFA) concentrations. Conclusions: We successfully induced frank diabetes by IV administering a single dose of pharmaceutical-grade STZ safely and without adverse events in conscious tethered baboons.

Idioma originalEnglish (US)
Páginas (desde-hasta)202-217
Número de páginas16
PublicaciónJournal of medical primatology
EstadoPublished - 2015

ASJC Scopus subject areas

  • Animal Science and Zoology
  • General Veterinary


Profundice en los temas de investigación de 'Successful pharmaceutical-grade streptozotocin (STZ)-induced hyperglycemia in a conscious tethered baboon (Papio hamadryas) model'. En conjunto forman una huella única.

Citar esto